3138 results for «3128»
3138 results
ACS: multimodality imaging saves the day
16 May 2024 – From EuroPCR 2024
This session explores various challenging acute coronary syndrome (ACS) cases where multimodality imaging, such as emergency cardiac CT, IVUS, and other techniques, played a crucial role in diagnosis and management. The cases cover a wide range of scenarios, including right coronary artery ACS, STEMI with a...
The uncrossable lesion
16 May 2024 – From EuroPCR 2024
This session delves into the challenges of dealing with uncrossable and heavily calcified coronary lesions. It features a variety of cases showcasing the use of specialized techniques and tools, such as the excimer laser, to overcome these obstacles. The session emphasizes the importance of troubleshooting, utilizing...
When imaging guides PCI complications management
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions highlighting the role of imaging in managing complications during percutaneous coronary interventions (PCI). Experts will present and discuss cases involving recurrent acute myocardial infarction, stent crumpling, and other unexpected complications, demonstrating how the use of various imaging...
When mitral valve intervention goes wrong
16 May 2024 – From EuroPCR 2024
This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...
Pushing the limits of transcatheter mitral valve interventions
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions showcasing the latest advancements and challenges in transcatheter mitral valve interventions. Experts will present and discuss complex cases involving severely calcified mitral valves, mitral valve-in-ring implantations, and the management of mitral regurgitation associated with hypertrophic obstructive cardiomyopathy....
Make your life easier with imaging during primary PCI for acute coronary syndrome
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions highlighting the use of imaging modalities, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), during primary percutaneous coronary interventions (PCI) for acute coronary syndrome. Experts will present and discuss challenging cases, demonstrating how the integration...
Intracoronary imaging: diagnosis
16 May 2024 – From EuroPCR 2024
This session highlights the pivotal role of intracoronary imaging techniques, such as OCT and IVUS, in the diagnosis of various cardiovascular conditions. The presenters share case studies that demonstrate how these imaging modalities can help differentiate acute coronary syndrome from other conditions, identify the underlying causes...
The future of interventional cardiology imaging
15 May 2024 – From EuroPCR 2024
Explore this session to discover the latest innovations in interventional cardiology images, including the benefits of artificial intelligence and angio-CT in PCI/SHD procedures. Learn about Alphenix Evolve and the initial experiences with AI imaging in daily cathlab practice, alongside intraprocedural angio-CT guided LAAO, and engage in...
Calcified coronary lesions: procedural techniques - Part 1
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on procedural techniques for the management of calcified coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of angio-based FFR, OCT, rotational atherectomy, and drug-coated balloons,...
PCI in patients with diabetes: next generation DES + DCB stent platform in action
14 May 2024 – From EuroPCR 2024
Watch this session on PCI in diabetic patients to learn about a groundbreaking technology addressing the complexities of this critical subgroup. Discover the next-generation DES and DCB stent platform and the innovative Envisolution technology behind it. Understand how it works, its advantages in managing complex cases,...
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
STEMI: thrombus is the problem
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the management of STEMI patients with a high thrombotic burden. Attendees will have the opportunity to explore various strategies and techniques, such as the use of pharmacomechanical thromboaspiration, prevention of...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
When using left ventricular support during PCI
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of left ventricular support devices, such as the Impella, during percutaneous coronary interventions. Attendees will have the opportunity to explore various scenarios, including the management of Impella impaction,...
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
When the pulmonary valve is the problem
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the management of pulmonary valve-related issues. Attendees will have the opportunity to explore various scenarios, including pulmonary balloon valvotomy in dextrocardia, transcatheter pulmonary valve implantation in dilated right ventricular outflow...
PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
DCB PCI in restenosis and de novo lesions
14 May 2024 – From EuroPCR 2024
This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of drug-coated balloons (DCB) in the management of restenosis and de novo coronary lesions. Attendees will have the opportunity to explore various strategies, including the use of a...
